Pharmaceutical Industry Factory of the Future | ARC Advisory Group The new pharmaceutical enterprise business model requires dramatic changes in drug discovery, clinical research, and clinical and commercial manufacturing. Client Challenges The business and regulatory environment in the pharmaceutical industry is changing rapidly and this pharmaceutical company recognized the need to define their new business model and strategic execution plan. The new risk based regulatory approach to enforcement of current Good Manufacturing Practices is increasing the need for a well documented approach to compliance. New bio-medical technology and socio-political price and delivery pressures are changing pricing structures, product portfolio mixes, and shortening commercial product life cycles. Del

Join for free to read